Envestnet Asset Management Inc. Purchases 222 Shares of Transcat, Inc. (NASDAQ:TRNS)

Envestnet Asset Management Inc. raised its position in shares of Transcat, Inc. (NASDAQ:TRNSGet Rating) by 0.9% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,071 shares of the scientific and technical instruments company’s stock after acquiring an additional 222 shares during the period. Envestnet Asset Management Inc. owned approximately 0.33% of Transcat worth $1,424,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in TRNS. Comerica Bank boosted its holdings in shares of Transcat by 188.3% during the first quarter. Comerica Bank now owns 15,974 shares of the scientific and technical instruments company’s stock worth $1,287,000 after acquiring an additional 10,433 shares during the period. Advisor Group Holdings Inc. boosted its stake in shares of Transcat by 95.5% in the first quarter. Advisor Group Holdings Inc. now owns 5,107 shares of the scientific and technical instruments company’s stock valued at $414,000 after buying an additional 2,495 shares during the period. Qube Research & Technologies Ltd bought a new stake in shares of Transcat in the first quarter valued at approximately $262,000. Essex Investment Management Co. LLC boosted its stake in shares of Transcat by 4.9% in the first quarter. Essex Investment Management Co. LLC now owns 28,645 shares of the scientific and technical instruments company’s stock valued at $2,324,000 after buying an additional 1,330 shares during the period. Finally, Howe & Rusling Inc. boosted its stake in shares of Transcat by 5.7% in the first quarter. Howe & Rusling Inc. now owns 36,616 shares of the scientific and technical instruments company’s stock valued at $2,971,000 after buying an additional 1,965 shares during the period. Institutional investors own 80.64% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on TRNS. HC Wainwright boosted their price target on Transcat from $85.00 to $88.00 and gave the company a “buy” rating in a research note on Wednesday, November 2nd. StockNews.com began coverage on Transcat in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. Finally, Northland Securities started coverage on Transcat in a research note on Thursday, September 15th. They issued an “outperform” rating and a $100.00 price target for the company. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $87.25.

Transcat Stock Down 3.0 %

NASDAQ TRNS opened at $80.97 on Tuesday. The business has a fifty day moving average price of $75.95 and a two-hundred day moving average price of $69.64. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.52 and a quick ratio of 1.84. Transcat, Inc. has a fifty-two week low of $50.32 and a fifty-two week high of $101.05. The stock has a market capitalization of $611.97 million, a PE ratio of 61.34 and a beta of 0.77.

Insiders Place Their Bets

In other news, Director Richard J. Harrison sold 2,509 shares of the company’s stock in a transaction on Thursday, November 3rd. The shares were sold at an average price of $71.97, for a total transaction of $180,572.73. Following the completion of the transaction, the director now directly owns 25,017 shares in the company, valued at $1,800,473.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 4.80% of the company’s stock.

Transcat Profile

(Get Rating)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.